Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

It was no surprise to many in healthcare that it advised a second dose for those 65 and older or for those younger who are moderately or severely immunocompromised. What was somewhat unexpected ...

The CDC now recommends that people 65 and older or those who are moderately to severely immunocompromised consult a health care provider about a second COVID-19 vaccine dose.

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Noroviruses are increasingly recognized as an important cause of chronic gastroenteritis in immunocompromised patients, as reflected by the growing number of clinical case reports. This review ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Researchers evaluated the immunogenicity of hepatitis A virus vaccination as well as responses in patients with HIV and those on immunosuppressive therapy.

ExeVir's XVR013m, COVID-19 program focuses on addressing the high unmet medical need to protect and treat immunocompromised and elderly individuals that account for respectively 4% and 10% of the ...

Future Market Insights (FMI) has released a comprehensive analysis on the global fungal staining reagent market, revealing a promising growth trajectory. The market is estimated to be valued at USD ...